Evidence map›Paper›PMID 36282588›Full record

ArticleCirculation. Genomic and precision medicine2022

Patient and Clinician Perceptions of Precision Cardiology Care: Findings From the HeartCare Study.

Hadley Stevens Smith, Clarissa E Sanchez, Ronald Maag, Alexandria Buentello, David R Murdock, Ginger A Metcalf, Trevor D Hadley, Daniel L Riconda, Eric Boerwinkle, Xander H T Wehrens and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Circulation. Genomic and precision medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. An integrated cardiometabolic genetic testing program in a predominantly Hispanic population within a community setting.Genetics in medicine : official journal of the American College of Medical Genetics · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Hadley Stevens SmithCenter for Medical Ethics & Health Policy, Baylor College of Medicine, Houston, TX (H.S.S., C.E.S., A.L.M., S.P.).ORCID 0000-0003-1247-6535
Clarissa E SanchezCenter for Medical Ethics & Health Policy, Baylor College of Medicine, Houston, TX (H.S.S., C.E.S., A.L.M., S.P.).ORCID 0000-0001-6510-6242
Ronald MaagDept of Medicine, Section of Cardiology & Cardiovascular Research, Baylor College of Medicine, Houston, TX (R.M., A.B., T.D.H., E.B., X.H.T.W., C.M.B.).
Alexandria BuentelloDept of Medicine, Section of Cardiology & Cardiovascular Research, Baylor College of Medicine, Houston, TX (R.M., A.B., T.D.H., E.B., X.H.T.W., C.M.B.).
David R MurdockHuman Genome Sequencing Center, Baylor College of Medicine, Houston, TX (D.R.M., G.A.M., E.B., R.A.G.).
Ginger A MetcalfHuman Genome Sequencing Center, Baylor College of Medicine, Houston, TX (D.R.M., G.A.M., E.B., R.A.G.).ORCID 0000-0002-8316-0071
Trevor D HadleyDept of Medicine, Section of Cardiology & Cardiovascular Research, Baylor College of Medicine, Houston, TX (R.M., A.B., T.D.H., E.B., X.H.T.W., C.M.B.).
Daniel L RicondaDept of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX (D.L.R.).
Eric BoerwinkleDept of Medicine, Section of Cardiology & Cardiovascular Research, Baylor College of Medicine, Houston, TX (R.M., A.B., T.D.H., E.B., X.H.T.W., C.M.B.).ORCID 0000-0001-8813-0544
Xander H T WehrensDept of Medicine, Section of Cardiology & Cardiovascular Research, Baylor College of Medicine, Houston, TX (R.M., A.B., T.D.H., E.B., X.H.T.W., C.M.B.).ORCID 0000-0001-5044-672X
Christie M BallantyneDept of Medicine, Section of Cardiology & Cardiovascular Research, Baylor College of Medicine, Houston, TX (R.M., A.B., T.D.H., E.B., X.H.T.W., C.M.B.).ORCID 0000-0002-6432-1730
Richard A GibbsHuman Genome Sequencing Center, Baylor College of Medicine, Houston, TX (D.R.M., G.A.M., E.B., R.A.G.).
Amy L McGuireCenter for Medical Ethics & Health Policy, Baylor College of Medicine, Houston, TX (H.S.S., C.E.S., A.L.M., S.P.).ORCID 0000-0002-7819-519X
Stacey PereiraCenter for Medical Ethics & Health Policy, Baylor College of Medicine, Houston, TX (H.S.S., C.E.S., A.L.M., S.P.).ORCID 0000-0001-6541-3904
Baylor College of Medicine · US

Funding

An ELSI-Integrated Evaluation of the Family-Level Utility of Pediatric Genomic SequencingK99HG011491 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI SMITH, HADLEY STEVENS · 2021 to 2022
$164k
NHGRI NIH HHS K99 HG011491
6 · The paper itself

Abstract

backgroundRoutine genome-wide screening for cardiovascular disease risk may inform clinical decision-making. However, little is known about whether clinicians and patients would find such testing useful or acceptable within the context of a genomics-enabled learning health system.

methodsWe conducted surveys with patients and their clinicians who were participating in the HeartCare Study, a precision cardiology care project that returned results from a next-generation sequencing panel of 158 genes associated with cardiovascular disease risk. Six weeks after return of results, we assessed patients' and clinicians' perceived utility and disutility of HeartCare, the effect of the test on clinical recommendations, and patients' attitudes toward integration of research and clinical care.

resultsAmong 666 HeartCare patients with a result returned during the survey study period, 42.0% completed a full or partial survey. Patient-participants who completed a full survey (n=224) generally had positive perceptions of HeartCare independent of whether they received a positive or negative result. Most patient-participants considered genetic testing for cardiovascular disease risk to have more benefit than risk (88.3%) and agreed that it provided information that they wanted to know (81.2%), while most disagreed that the test caused them to feel confused (77.7%) or overwhelmed (78.0%). For 122 of their patients with positive results, clinicians (n=13) reported making changes in clinical care for 66.4% of patients, recommending changes in health behaviors for 36.9% of patients, and recommending to 33.6% of patients that their family members have clinical testing.

conclusionsBoth patients and clinicians thought the HeartCare panel screen for cardiovascular disease risk provided information that was useful in terms of personal or health benefits to the patient and that informed clinical care without causing patients to be confused or overwhelmed. Further research is needed to assess perceptions of genome-wide screening among the US cardiology clinic population.

Indexed as

CardiologyCardiovascular DiseasesClinical Decision-MakingFamilyHumansSurveys and Questionnairescardiovascular diseasepatient-reported outcomespolygenic risk scores

Identifiers

PMID36282588
PMCPMC10163837
OpenAlexW4307233913

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.